Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
Top Cited Papers
- 3 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Rheumatology International
- Vol. 41 (2), 243-256
- https://doi.org/10.1007/s00296-020-04764-5
Abstract
Comorbidities in rheumatic and musculoskeletal diseases (RMDs) not only increase morbidity and mortality but also confound disease activity, limit drug usage and increase chances of severe infections or drug-associated adverse effects. Most RMDs lead to accelerated atherosclerosis and variable manifestations of the metabolic syndrome. Literature on COVID-19 in patients with RMDs, and the effects of various comorbidities on COVID-19 was reviewed. The initial data of COVID-19 infections in RMDs have not shown an increased risk for severe disease or the use of different immunosuppression. However, there are some emerging data that patients with RMDs and comorbidities may fare worse. Various meta-analyses have reiterated that pre-existing hypertension, cardiovascular disease, stroke, diabetes, chronic kidney disease, heart failure, lung disease or obesity predispose to increased COVID-19 mortality. All these comorbidities are commonly encountered in the various RMDs. Presence of comorbidities in RMDs pose a greater risk than the RMDs themselves. A risk score based on comorbidities in RMDs should be developed to predict severe COVID-19 and death. Additionally, there should be active management of such comorbidities to mitigate these risks. The pandemic must draw our attention towards, and not away from, comorbidities.This publication has 156 references indexed in Scilit:
- Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: A cross-sectional studySeminars in Arthritis and Rheumatism, 2014
- Vitamin D and rheumatic diseasesReumatismo, 2014
- Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort studyRheumatology, 2013
- The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisRheumatology, 2013
- YOGA FOR DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSISDepression and Anxiety, 2013
- A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcomeRheumatology, 2012
- Writing a narrative biomedical review: considerations for authors, peer reviewers, and editorsRheumatology International, 2011
- Immune suppression and immune activation in depressionBrain, Behavior, and Immunity, 2011
- Pain, catastrophizing, and depression in the rheumatic diseasesNature Reviews Rheumatology, 2011
- Should all patients with systemic lupus erythematosus receive cardioprotection with statins?Nature Clinical Practice Rheumatology, 2007